KRAS Genotyping of Paraffin-Embedded Colorectal Cancer Tissue in Routine Diagnostics
- 1 January 2010
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 12 (1) , 35-42
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal CancerNew England Journal of Medicine, 2008
- KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance programVirchows Archiv, 2008
- High-Resolution Melting Analysis for Rapid Detection ofKRAS, BRAF,andPIK3CAGene Mutations in Colorectal CancerAmerican Journal of Clinical Pathology, 2008
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990sEuropean Journal of Cancer, 2008
- Targeted therapy of cancer: new roles for pathologists in colorectal cancerLaboratory Investigation, 2008
- Systemic Treatment of Colorectal CancerGastroenterology, 2008
- Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With CetuximabJournal of Clinical Oncology, 2008
- Sensitive Sequencing Method for KRAS Mutation Detection by PyrosequencingThe Journal of Molecular Diagnostics, 2005
- Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor ReceptorJournal of Clinical Oncology, 2004